0.245
price down icon32.43%   -0.1176
after-market Dopo l'orario di chiusura: .25 0.005 +2.04%
loading
Precedente Chiudi:
$0.3626
Aprire:
$0.2701
Volume 24 ore:
909.58K
Relative Volume:
0.93
Capitalizzazione di mercato:
$1.03M
Reddito:
$7.33M
Utile/perdita netta:
$-21.20M
Rapporto P/E:
-0.268
EPS:
-0.9143
Flusso di cassa netto:
$-12.68M
1 W Prestazione:
-45.95%
1M Prestazione:
-81.15%
6M Prestazione:
-94.15%
1 anno Prestazione:
-96.64%
Intervallo 1D:
Value
$0.24
$0.3449
Intervallo di 1 settimana:
Value
$0.24
$0.4725
Portata 52W:
Value
$0.24
$7.80

Prophase Labs Inc Stock (PRPH) Company Profile

Name
Nome
Prophase Labs Inc
Name
Telefono
(215) 345-0919
Name
Indirizzo
711 STEWART AVE, SUITE 200, NEW YORK, PA
Name
Dipendente
96
Name
Cinguettio
Name
Prossima data di guadagno
2025-05-20
Name
Ultimi documenti SEC
Name
PRPH's Discussions on Twitter

Confronta PRPH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
PRPH
Prophase Labs Inc
0.245 1.52M 7.33M -21.20M -12.68M -0.9143
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
620.72 229.63B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
236.59 166.25B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
706.83 54.48B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
A
Agilent Technologies Inc
147.60 40.52B 6.95B 1.30B 1.15B 4.5696
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
240.53 39.95B 15.90B 1.28B 2.21B 7.2842

Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-12-20 Iniziato H.C. Wainwright Buy
2021-10-13 Downgrade Dawson James Buy → Neutral
2021-01-20 Iniziato Dawson James Buy

Prophase Labs Inc Borsa (PRPH) Ultime notizie

pulisher
Jan 06, 2026

ProPhase Labs, Inc.(NasdaqCM: PRPH) dropped from S&P TMI Index - marketscreener.com

Jan 06, 2026
pulisher
Jan 05, 2026

How one lab swapped $3.3M of debt for shares, jolting its stock price - Stock Titan

Jan 05, 2026
pulisher
Jan 03, 2026

MSN Money - MSN

Jan 03, 2026
pulisher
Jan 02, 2026

ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - MSN

Jan 02, 2026
pulisher
Jan 02, 2026

ProPhase Labs faces Nasdaq delisting, plans appeal, OTC move - TipRanks

Jan 02, 2026
pulisher
Jan 02, 2026

ProPhase Labs Received Notice of Delisting - TradingView — Track All Markets

Jan 02, 2026
pulisher
Jan 01, 2026

ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles - MSN

Jan 01, 2026
pulisher
Dec 29, 2025

ProPhase Labs FY 2024 Earnings Preview - MSN

Dec 29, 2025
pulisher
Dec 26, 2025

ProPhase Labs (PRPH) Stock Price, Quote, News & History - Benzinga

Dec 26, 2025
pulisher
Dec 23, 2025

ProPhase Labs Inc. (NASDAQ: PRPH)Share Price - intelligentinvestor.com.au

Dec 23, 2025
pulisher
Dec 23, 2025

Tranche Update on ProPhase Labs, Inc.'s Equity Buyback Plan announced on March 15, 2023. - marketscreener.com

Dec 23, 2025
pulisher
Dec 22, 2025

ProPhase Labs signs non-binding LOI for proposed reverse merger with ABL - MSN

Dec 22, 2025
pulisher
Dec 22, 2025

ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025 - ts2.tech

Dec 22, 2025
pulisher
Dec 21, 2025

ProPhase Labs jumps as it signs LOI for reverse merger with Advanced Biological Laboratories - MSN

Dec 21, 2025
pulisher
Dec 21, 2025

ProPhase Labs Earnings Notes - Trefis

Dec 21, 2025
pulisher
Dec 20, 2025

ProPhase Labs announces proposed reverse merger with ABL - MSN

Dec 20, 2025
pulisher
Dec 19, 2025

ProPhase Labs trading halted, news pending - MSN

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs Announces Proposed Reverse Merger with ABL - TipRanks

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs and ABL announce reverse merger plans By Investing.com - Investing.com Nigeria

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs files replacement legal opinion with new counsel By Investing.com - Investing.com Nigeria

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs files replacement legal opinion with new counsel - Investing.com

Dec 19, 2025
pulisher
Dec 19, 2025

PRPH: Reverse merger LOI, $50M receivables recovery, and BE-Smart test commercialization advance - TradingView — Track All Markets

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs announces LOI for reverse merger with Advanced Biological - Proactive financial news

Dec 19, 2025
pulisher
Dec 19, 2025

Will ProPhase Labs Inc. stock outperform Nasdaq index2025 AllTime Highs & Weekly High Return Stock Opportunities - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs stock soars after announcing reverse merger with ABL By Investing.com - Investing.com Nigeria

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs (PRPH) Surges on Proposed Reverse Merger with ABL - GuruFocus

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs stock soars after announcing reverse merger with ABL - Investing.com

Dec 19, 2025
pulisher
Dec 19, 2025

PRPH: Proposed reverse merger gives ABL majority control and delivers near-term value to shareholders - TradingView — Track All Markets

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs, Advanced Biological Laboratories Sign Letter of Intent for Reverse Merger - marketscreener.com

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs, Inc. to Declare A Special Cash Dividend - marketscreener.com

Dec 19, 2025
pulisher
Dec 19, 2025

What risks investors should watch in ProPhase Labs Inc. stockMarket Movement Recap & Capital Efficiency Focused Ideas - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Why Is Prophase Labs Stock (PRPH) Up Today? - TipRanks

Dec 19, 2025
pulisher
Dec 19, 2025

How ProPhase Labs Inc. stock compares to market leadersWeekly Risk Summary & Reliable Intraday Trade Plans - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Advanced Biological Laboratories S.A. signed a non-binding letter of intent to acquire ProPhase Labs, Inc. in a reverse merger transaction. - marketscreener.com

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs (PRPH) Explores Reverse Merger with ABL - GuruFocus

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs signs non-binding LOI for proposed reverse merger with Advanced Biological Laboratories - marketscreener.com

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase’s proposed ABL merger could mean cash payout for holders - Stock Titan

Dec 19, 2025
pulisher
Dec 19, 2025

Trading Recap: Is ProPhase Labs Inc. stock a safe haven assetQuarterly Portfolio Summary & Real-Time Chart Breakout Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

ABL Diagnostics Informs the Market of a Non‑Binding Letter of Intent Between ABL S.A. and ProPhase Labs (Nasdaq: PRPH) for a Proposed Reverse Merger - Business Wire

Dec 19, 2025
pulisher
Dec 19, 2025

ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories - Sahm

Dec 19, 2025
pulisher
Dec 18, 2025

ProPhase Labs (NASDAQ: PRPH) sets 1-for-10 reverse stock split effective Dec. 22 - Stock Titan

Dec 18, 2025
pulisher
Dec 18, 2025

Will ProPhase Labs Inc. stock remain a Wall Street favoriteWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - Улправда

Dec 18, 2025
pulisher
Dec 15, 2025

Prophase Labs Faces Unsealed Civil Action Disclosure - MSN

Dec 15, 2025
pulisher
Dec 13, 2025

Prophase Labs Implements Reverse Stock Split - The Globe and Mail

Dec 13, 2025
pulisher
Dec 12, 2025

ProPhase Labs Delays Q3 Filing Amid Reorganization - MSN

Dec 12, 2025
pulisher
Dec 11, 2025

ProPhase Labs (NASDAQ: PRPH) completes 1-for-10 reverse stock split, 5.77M shares outstanding - Stock Titan

Dec 11, 2025
pulisher
Dec 08, 2025

The growth track for ProPhase Labs Inc (PRPH) has changed recently - setenews.com

Dec 08, 2025
pulisher
Dec 05, 2025

Is ProPhase Labs Inc. stock a buy in volatile marketsIPO Watch & Technical Entry and Exit Tips - Newser

Dec 05, 2025

Prophase Labs Inc Azioni (PRPH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research LH
$260.40
price up icon 2.85%
$147.11
price up icon 4.09%
diagnostics_research WAT
$400.54
price up icon 1.41%
diagnostics_research MTD
$1,485.15
price up icon 2.66%
$248.74
price up icon 4.77%
diagnostics_research IQV
$240.53
price up icon 2.53%
Capitalizzazione:     |  Volume (24 ore):